Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

May 01, 1994; Volume 45,Issue 5
  • You have access
    Sensitivity of the N-methyl-D-aspartate receptor to polyamines is controlled by NR2 subunits.
    K Williams, A M Zappia, D B Pritchett, Y M Shen and P B Molinoff
    Molecular Pharmacology May 1994, 45 (5) 803-809;
  • You have access
    Impact of beta and gamma variants on ligand-binding properties of gamma-aminobutyric acid type A receptors.
    H Lüddens, P H Seeburg and E R Korpi
    Molecular Pharmacology May 1994, 45 (5) 810-814;
  • You have access
    Inhibition of NADPH-oxidase activity in human polymorphonuclear neutrophils by lipophilic ascorbic acid derivatives.
    E Schmid, V Figala and V Ullrich
    Molecular Pharmacology May 1994, 45 (5) 815-825;
  • You have access
    5-Hydroxytryptamine type 2A receptors regulate cyclic AMP accumulation in a neuronal cell line by protein kinase C-dependent and calcium/calmodulin-dependent mechanisms.
    K A Berg, W P Clarke, Y Chen, B J Ebersole, R D McKay and S Maayani
    Molecular Pharmacology May 1994, 45 (5) 826-836;
  • You have access
    Reinforcement effect of histamine on the differentiation of murine myeloblasts and promyelocytes: externalization of granulocyte colony-stimulating factor receptors induced by histamine.
    K Tasaka, M Doi, N Nakaya and M Mio
    Molecular Pharmacology May 1994, 45 (5) 837-845;
  • You have access
    Expression of mRNAs encoding subunits of the N-methyl-D-aspartate receptor in cultured cortical neurons.
    J Zhong, S L Russell, D B Pritchett, P B Molinoff and K Williams
    Molecular Pharmacology May 1994, 45 (5) 846-853;
  • You have access
    Alternative splicing of human inwardly rectifying K+ channel ROMK1 mRNA.
    H Yano, L H Philipson, J L Kugler, Y Tokuyama, E M Davis, M M Le Beau, D J Nelson, G I Bell and J Takeda
    Molecular Pharmacology May 1994, 45 (5) 854-860;
  • You have access
    A carboxyl-terminally truncated mutant and nonglycosylated A2a adenosine receptors retain ligand binding.
    C E Piersen, C D True and J N Wells
    Molecular Pharmacology May 1994, 45 (5) 861-870;
  • You have access
    125I-2-[4-[2-[2-[(4-azidophenyl)methylcarbonylamino] ethylaminocarbonyl]ethyl]phenyl] ethylamino-5'-N-ethylcarboxamidoadenosine labels transmembrane span V of the A2a adenosine receptor.
    C E Piersen, C D True and J N Wells
    Molecular Pharmacology May 1994, 45 (5) 871-877;
  • You have access
    The D2S and D2L dopamine receptor isoforms are differentially regulated in Chinese hamster ovary cells.
    L J Zhang, J E Lachowicz and D R Sibley
    Molecular Pharmacology May 1994, 45 (5) 878-889;
  • You have access
    Transfected muscarinic acetylcholine receptors selectively couple to Gi-type G proteins and Gq/11.
    S Offermanns, T Wieland, D Homann, J Sandmann, E Bombien, K Spicher, G Schultz and K H Jakobs
    Molecular Pharmacology May 1994, 45 (5) 890-898;
  • You have access
    Characterization of [3H]Ba 679 BR, a slowly dissociating muscarinic antagonist, in human lung: radioligand binding and autoradiographic mapping.
    E B Haddad, J C Mak and P J Barnes
    Molecular Pharmacology May 1994, 45 (5) 899-907;
  • You have access
    Influence of structural modifications at the 3' and 4' positions of doxorubicin on the drug ability to trap topoisomerase II and to overcome multidrug resistance.
    G Capranico, R Supino, M Binaschi, L Capolongo, M Grandi, A Suarato and F Zunino
    Molecular Pharmacology May 1994, 45 (5) 908-915;
  • You have access
    Elevation of glutathione levels by phase II enzyme inducers: lack of inhibition of human immunodeficiency virus type 1 replication in chronically infected monocytoid cells.
    H J Prochaska, L Rubinson, Y Yeh, P Baron and B Polsky
    Molecular Pharmacology May 1994, 45 (5) 916-921;
  • You have access
    Effects of tyrphostins on the activated c-src protein in NIH/3T3 cells.
    W K Agbotounou, A Levitzki, A Jacquemin-Sablon and J Pierre
    Molecular Pharmacology May 1994, 45 (5) 922-931;
  • You have access
    Biodistribution and metabolism of internally 3H-labeled oligonucleotides. I. Comparison of a phosphodiester and a phosphorothioate.
    H Sands, L J Gorey-Feret, A J Cocuzza, F W Hobbs, D Chidester and G L Trainor
    Molecular Pharmacology May 1994, 45 (5) 932-943;
  • You have access
    Short and long term effects of cytoskeleton-disrupting drugs on cytochrome P450 Cyp1a-1 induction in murine hepatoma 1c1c7 cells: suppression by the microtubule inhibitor nocodazole.
    A Schöller, N J Hong, P Bischer and J J Reiners
    Molecular Pharmacology May 1994, 45 (5) 944-954;
  • You have access
    Template 2-chloro-2'-deoxyadenosine monophosphate inhibits in vitro DNA synthesis.
    P Hentosh and P Grippo
    Molecular Pharmacology May 1994, 45 (5) 955-961;
  • You have access
    Cross-resistance to antitumor diarylsulfonylureas and collateral sensitivity to mitochondrial toxins in a human cell line selected for resistance to the antitumor agent N-(5-indanylsulfonyl)-N'-(4-chlorophenyl)urea.
    J Sosinski, J H Thakar, G S Germain, P Dias, F C Harwood, J F Kuttesch and P J Houghton
    Molecular Pharmacology May 1994, 45 (5) 962-970;
  • You have access
    Activation of rat Kupffer cells to tumoricidal cells by the immunomodulator muramyl tripeptide-phosphatidylethanolamine incorporated into the novel drug carrier lactosylated low density lipoprotein.
    B van de Water, T J van Berkel and J Kuiper
    Molecular Pharmacology May 1994, 45 (5) 971-977;
  • You have access
    125I-4-aminobenzyl-5'-N-methylcarboxamidoadenosine, a high affinity radioligand for the rat A3 adenosine receptor.
    M E Olah, C Gallo-Rodriguez, K A Jacobson and G L Stiles
    Molecular Pharmacology May 1994, 45 (5) 978-982;
  • You have access
    Role of acidic amino acids in the allosteric modulation by gallamine of antagonist binding at the m2 muscarinic acetylcholine receptor.
    R A Leppik, R C Miller, M Eck and J L Paquet
    Molecular Pharmacology May 1994, 45 (5) 983-990;
  • You have access
    5-Hydroxytryptamine type 2A and 2C receptors linked to Na+/K+/Cl- cotransport.
    S E Mayer and E Sanders-Bush
    Molecular Pharmacology May 1994, 45 (5) 991-996;
  • You have access
    Interaction of delta-opioid receptors with multiple G proteins: a non-relationship between agonist potency to inhibit adenylyl cyclase and to activate G proteins.
    P L Prather, H H Loh and P Y Law
    Molecular Pharmacology May 1994, 45 (5) 997-1003;
  • You have access
    Ethanol inhibits the function of 5-hydroxytryptamine type 1c and muscarinic M1 G protein-linked receptors in Xenopus oocytes expressing brain mRNA: role of protein kinase C.
    E Sanna, J E Dildy-Mayfield and R A Harris
    Molecular Pharmacology May 1994, 45 (5) 1004-1012;
  • You have access
    Control of calcium spiking frequency in pituitary gonadotrophs by a single-pool cytoplasmic oscillator.
    S S Stojilkovic, M Tomic, M Kukuljan and K J Catt
    Molecular Pharmacology May 1994, 45 (5) 1013-1021;
  • You have access
    Properties and regulation of the coupling to adenylate cyclase of secretin receptors stably transfected in Chinese hamster ovary cells.
    J P Vilardaga, E Ciccarelli, C Dubeaux, P De Neef, A Bollen and P Robberecht
    Molecular Pharmacology May 1994, 45 (5) 1022-1028;
  • You have access
    Signal transduction by the cloned glucagon-like peptide-1 receptor: comparison with signaling by the endogenous receptors of beta cell lines.
    C Widmann, E Bürki, W Dolci and B Thorens
    Molecular Pharmacology May 1994, 45 (5) 1029-1035;
  • You have access
    A single species of A1 adenosine receptor expressed in Chinese hamster ovary cells not only inhibits cAMP accumulation but also stimulates phospholipase C and arachidonate release.
    M Akbar, F Okajima, H Tomura, S Shimegi and Y Kondo
    Molecular Pharmacology May 1994, 45 (5) 1036-1042;
  • You have access
    Protein kinase C-dependent regulation of sulfidopeptide leukotriene biosynthesis and leukotriene C4 synthase in neutrophilic HL-60 cells.
    S Kargman, A Ali, J P Vaillancourt, J F Evans and D W Nicholson
    Molecular Pharmacology May 1994, 45 (5) 1043-1049;
  • You have access
    Intracellular sodium concentration in cultured cerebellar granule cells challenged with glutamate.
    L Kiedrowski, J T Wroblewski and E Costa
    Molecular Pharmacology May 1994, 45 (5) 1050-1054;
  • You have access
    Block of the rat brain IIA sodium channel alpha subunit by the neuroprotective drug riluzole.
    T Hebert, P Drapeau, L Pradier and R J Dunn
    Molecular Pharmacology May 1994, 45 (5) 1055-1060;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 45, Issue 5
1 May 1994
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics